Recent developments in the chemotherapy of schistosomiasis.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use; D002648:Child; D006224:Cricetinae; D004352:Drug Resistance, Microbial; D005029:Ethylenediamines / Q000627:therapeutic use; D000882:Haplorhini; D006801:Humans; D008154:Lucanthone / Q000627:therapeutic use; D008251:Macaca; D000432:Methanol / Q000627:therapeutic use; D051379:Mice; D009560:Niridazole / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D009581:Nitrofurans / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D012548:Schistosoma haematobium; D012550:Schistosoma mansoni; D012552:Schistosomiasis / Q000188:drug therapy*; D013045:Species Specificity; D013329:Structure-Activity Relationship; D014052:Toluidines / Q000627:therapeutic use; D014966:Xanthenes / Q000627:therapeutic use
D000871:Anthelmintics; D005029:Ethylenediamines; D009581:Nitrofurans; D010879:Piperazines; D010880:Piperidines; D014052:Toluidines; D014966:Xanthenes; D008154:Lucanthone; D009560:Niridazole; D000432:Methanol